cs.AINov 17, 2026

Right Diagnosis, Unsafe Route: Auditing Clinical AI Decision Trajectories and Corrective Oversight for Validity and Potential Harm

Authors: Guanqiao Chen, Wei Jiang, Shu Zhang, Qian Lin, Guanxu Yu, Siran Li, Chunhui Wang, Tianyu Shi

Organizations: New York University · Xi’an Jiaotong University · The University of Hong Kong · Independent Researcher · 

Abstract

A clinical AI system can reach a correct final diagnosis through intermediate decisions that could have harmed the patient, and can repair an error while introducing new risks. Most evaluations score final diagnoses; even stepwise benchmarks, which release a case's evidence over time, score whether systems reach the right diagnosis or gather the right information, not whether the decisions a patient passes through are safe. We make patient safety the target of stepwise evaluation. A trajectory audit replays real admissions checkpoint by checkpoint, lets each system decide with only the evidence released so far, and rates every test, treatment and disposition for its potential harm to the patient and, separately, for clinical validity, against the documented final diagnosis and physician-written disease rubrics yet on the evidence available when the decision was made. An LLM judge scores every decision, and a physician reference standard (triple annotation and senior adjudication of a stratified sample) calibrates the rates. An oversight audit branches each trajectory at its first actionable error and measures, on the same branches, whether corrective feedback repairs the error and whether it introduces new harm. Across 300 cases from a hospital cardiology cohort, MIMIC-IV and the public ASCENT benchmark, with up to seven AI systems per source, 55.2% of hospital trajectories reaching an acceptable final diagnosis passed through a decision with moderate or severe potential harm and 24.8% through a clinically unacceptable one; the harm rates were 76.2% on MIMIC-IV and 39.6% on ASCENT. Structured corrections resolved 73.6% of first errors versus 24.8% after bare rejection, yet new potentially unsafe decisions followed 30.2% of corrections versus 19.7% of rejections. A correct final diagnosis does not certify a safe trajectory, and a successful correction does not certify a safe recovery.

Figures & tables

Appendix figures & tables17 assets

Supplementary material from the paper’s appendix.

Appendix

Explore similar work

Jul 9, 2026

A safety-oriented hypothetico-deductive framework for AI-assisted differential diagnosis

Diagnostic error is a major threat to patient safety, yet current large language model (LLM) systems often treat diagnosis as a one-shot prediction task, lacking safeguards against missed high-risk alternatives or rigorous verification of their reasoning. Here, we present AegisDx, a safety-oriented framework for hypothetico-deductive clinical reasoning. AegisDx coordinates specialized LLM components through role-specific contracts, structured intermediate outputs, evidence-retrieval interfaces, and verification gates to generate broad differential diagnoses, enforce explicit screening for dangerous "must-not-miss" conditions, verify reasoning against grounded medical evidence, and structure actionable next steps. We evaluated AegisDx across three layers. On literature-derived case reports from NEJM and JAMA, with GPT-oss-120B as the shared backbone, Top-3 diagnostic accuracy was 59.9% versus 52.1% for the standalone LLM on JAMA cases and 62.7% versus 51.4% on NEJM cases. On cases from Annals of Emergency Medicine, Top-3 accuracy was 85.7% versus 68.6%; against physician-consensus must-not-miss diagnosis sets, AegisDx captured at least one such condition among its top three diagnoses in 78.0% of cases versus 52.0%. In a blinded physician evaluation of 43 real-world emergency department notes from the Yale New Haven Health System compared against GPT-5, AegisDx improved the physician-rated composite safety score from 4.31 to 4.55 on a 5-point scale (adjusted p = 2.1x10^-4), with qualitative gains in must-not-miss identification and reasoning safety. Our findings suggest that engineering diagnostic AI as a safety-oriented reasoning framework, rather than optimizing raw predictive accuracy alone, can provide a safer, more transparent, and clinically meaningful layer of bedside decision support for acute care workflows.
Aug 31, 2026

AI Morbidity and Mortality: A Framework for Clinical AI Failure Review

Clinical artificial intelligence is increasingly embedded in real-world care, yet existing safety mechanisms are poorly suited to reconstructing and learning from individual AI-related errors and near-misses. Aggregate model monitoring can identify performance changes, and traditional patient safety reporting can capture adverse events, but neither is designed to explain how risk emerges across the interaction among AI systems, clinicians, workflows, and institutional controls. We propose AI Morbidity and Mortality (AI M&M), a structured, blameless framework for case-based review of clinical AI failures. The framework combines standardized case intake, evidence preservation and investigator-level reconstruction, tool-in-loop attribution, and corrective-action tracking. Each event is classified across four linked dimensions: Trigger - Mechanism - Clinical Pathway - Corrective Action, separating the condition that exposed a vulnerability from the process that produced risk, its consequence for care, and the remediation assigned. We demonstrate the framework using five illustrative outpatient medication and clinical decision-support cases; two clinician reviewers independently applied all four classification axes and reached agreement across all 20 axis-level classifications. AI M&M is intended to complement, rather than replace, model monitoring, patient safety reporting, and regulatory oversight by converting individual AI-in-workflow failures into actionable institutional learning. Prospective evaluation across institutions, AI systems, and clinical settings is needed.
Mar 14, 2026

Clinician input steers AI toward accurate and harmful recommendations

Large language models (LLMs) are entering clinical workflows, yet evaluations rarely assess how clinician reasoning shapes model behavior during clinical interactions. Using 61 curated NEJM Case Records, we tested how expert or misleading clinician reasoning influenced AI-generated differential diagnoses and next step recommendations across 21 reasoning variants from 8 proprietary and open-source models. After clinician exposure, LLM-clinician concordance increased: simulations with >=3 overlapping differential diagnoses rose from 65.8% to 93.5%, and those with >=3 overlapping next step recommendations from 20.3% to 53.8%. Expert context significantly improved correct final-diagnosis inclusion in all 21 models (mean +20.4 pp), reflecting both improved reasoning and passive content echoing, while adversarial context significantly degraded performance in 14 models (mean -5.4 pp). Expert context also significantly increased leading-diagnosis accuracy in all 21 models, whereas adversarial context significantly reduced it in 13. Multi-turn disagreement challenges revealed distinct model phenotypes, from highly conformist to dogmatic, with adversarial arguments remaining a vulnerability even in otherwise resilient models. Inference-time scaling reduced harmful echoing of clinician-introduced recommendations across WHO harm-severity tiers by 62.7% for mild, 57.9% for moderate, 76.3% for severe, and 83.5% for death-tier recommendations. Inference-time prompting recovered diagnostic accuracy lost to adversarial context while preserving expert-context benefits across GPT-5, Claude Sonnet 4.5, and Gemini 3 Flash, and sharply reduced highly consistent harmful echoing across severity tiers. These findings provide a foundation for evaluating clinician-AI collaboration and introduce interactive metrics and mitigation strategies essential to safety and robustness.